Navigation Links
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
Date:6/12/2008

- Phase 2 data demonstrate sustained improvement in disease activity

through three years of LymphoStat-B (belimumab) therapy - - No increase in adverse events, malignancies, infections or laboratory

abnormalities over time -

ROCKVILLE, Md., June 12 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced the presentation of results from a long- term Phase 2 continuation trial showing that LymphoStat-B(R) (belimumab) was associated with sustained improvement in disease activity across multiple clinical measures, decreased frequency of disease flares, potential steroid- sparing activity, and was generally well tolerated through three years on treatment in combination with standard of care in patients with serologically active systemic lupus erythematosus (SLE). The results are the subject of a number of oral and poster presentations today in Paris at the 2008 Congress of the European League Against Rheumatism (EULAR).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"Based on the results presented at EULAR 2008, the clinical benefit observed for belimumab at Week 52 of this Phase 2 study appears to be durable through three years," said Richard Furie, M.D., Chief, Division of Rheumatology and Allergy-Clinical Immunology, North Shore Long Island Jewish Health System, Lake Success, NY, and Associate Professor of Medicine, New York University School of Medicine. "We observe that patients who crossed over from placebo to belimumab after Week 52 have also shown improvement across multiple clinical measures. The durability of clinical effect and the favorable safety p
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
2. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
3. Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
4. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
5. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
6. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
7. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
8. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
9. First Human Implant of New Archus Orthopedics Facet Replacement System
10. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
11. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Another option to prevent illnesses caused by s...ING, Md., Nov. 27 The U...riflu for people ages 18 years and older to preven... B. ,, (Logo: http://www.newscom.com/cgi-bin...ed by Novartis Vaccines and Diagnostics in Siena, ...
(Date:11/26/2009)... JOHANNESBURG, South Africa, Nov. 26 /PRNewswire/ ...any of the Year Award in the Generic Pharmaceutica... Limited. ,, (Logo: http://www.newscom.com/cgi...of the Year Award, the following criteria were use...key competitors: growth strategy and implementatio...
(Date:11/25/2009)...BEDFORD, Mass., Nov. 25 ...OLX ), a leading developer, manufacturer and suppl...s and surgical products dedicated to serving the h...ing of the Radiological Society of North America (...hrough December 3, 2009 to highlight our new Secur...
Breaking Medicine Technology:FDA Approves Agriflu Seasonal Influenza Vaccine 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Anxious Kids at Risk for Obesity in Adulthood 57251 1Anxious Kids at Risk for Obesity in Adulthood 57251 2The Celebrate Wellness Expo Presents Motivational Speaker 26 Author Dr Robin L Smith and Spiritual Teacher 26 Author Rev Michael Bernard Beckwith 57249 1The Celebrate Wellness Expo Presents Motivational Speaker 26 Author Dr Robin L Smith and Spiritual Teacher 26 Author Rev Michael Bernard Beckwith 57249 2Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 1Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 2Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 3
... NanoBio Corporation,announced today that it has s...its phase 2 study of NB-002, a topical lotion for ...remain confidential, the results clearly,justify c...ts., "Allowing adequate time for subjects to grow...infection will enable us to generate data on,compl...
...DM Pharma, Inc.,(the Company) (Nasdaq: IDMI ) ann... clinical protocol finalized with the U.S. Food an...rtide (L-MTP-PE) to eligible,high-risk osteosarcom... "This formalized study is in response to the incr... to L-MTP-PE," said Timothy P. Walbert,president a...
Other Medicine Technology:NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 2IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 3IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 4IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study 5
(Date:11/27/2009)..., Specialist manufacturer... products are saving millions of dollars by bringi...gn process. Increasing numbers of pro-active medic...experts at the concept stage of their projects, en...isting design processes or potentially outdated te...
(Date:11/26/2009)..., , PRINCETON, N.J., Nov. 27 /PRNewswir... will almost double over the next 25 years and ann...o hit $336 billion, up from $113 billion today, ac... of Diabetes Care . The National Changing Diabe...sk, commissioned the analysis by a team from the U...
(Date:11/26/2009)... Luggage that,s too big or too heavy can lead to s...ealthDay News) -- There may be nothing wrong with ...ht not want to do the same thing with your suitcas...,000 people were treated in 2008 in U.S. hospital ...er medical facilities for luggage-related injuries...
(Date:11/26/2009)..., Dr. David Kim of the Li...loss surgery in Dallas , is one of a growing numbe...ar social networking sites to connect with individ...eatment to fight morbid obesity. Dr. Kim is utiliz...information about his practice with the community....
(Date:11/26/2009)..., Ennis & Ennis, P.A....tions for users of Yaz and Yasmin birth control pi..., Pulmonary Embolism, Stroke, Heart Attack or othe...removed. Women can call toll free at 1-800-856-640....ennislaw.com and fill out an online case evaluat...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...ceive x-rays; however most believed,they were not ...of risk,varies with each case.,, HARRISBURG, Pa.,...zing radiation) in over 90 cases reported to the,P...ity,s March 2008 Patient Safety Advisory., Furthe...
...l Care,Affiliates ("SCA") today announced that it ... Eastern Time on Monday, March 31, 2008, to discus...2007. Please go to SCA,s,Intralinks website to obt...o obtain access to the website., Surgical Care Af...
...ascular problems in elite-level football players s... the lives of college and professional players. Ma...results of their new study of the cardiovascular h...ng and blockages in arteries, compared to the gene...
...an,Pharmaceutical Inc., the U.S. subsidiary of Jap...tical Co., Ltd., has agreed to pay more than,$4 mi...ify, an atypical,antipsychotic drug, for "off-labe...) to co-promote sales of the drug in the,United St...
...(Nasdaq:,CRYO), reported today that its Annual Rep..."going concern" qualification. The going-concern,q...dent registered public,accounting firm expressing ...ditional working capital. In its Annual,Report on ...
...rican adults considered to have normal body weight...ter than 20 percent for men and 30 percent for wom... new Mayo Clinic research shows. The finding confl... and a tendency to develop metabolic syndrome, whi...
Other Medicine News:Health News:Pennsylvania Patient Safety Authority Releases March Advisory Highlighting Communication Issues That Affect Patient Safety 2Health News:Pennsylvania Patient Safety Authority Releases March Advisory Highlighting Communication Issues That Affect Patient Safety 3Health News:Pennsylvania Patient Safety Authority Releases March Advisory Highlighting Communication Issues That Affect Patient Safety 4Health News:Mayo Clinic finds retired NFL players at increased risk for heart problems 2Health News:Mayo Clinic finds retired NFL players at increased risk for heart problems 3Health News:Otsuka to Pay More Than $4 Million to Resolve Off-Label Marketing Allegations Involving Abilify 2Health News:CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders' Equity 2Health News:CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders' Equity 3Health News:Normal weight obesity: An emerging risk factor for heart and metabolic problems 2Health News:Normal weight obesity: An emerging risk factor for heart and metabolic problems 3
Sterilized TowerPack Refill System D200
Finntip Wide 10-200ul, Sterile
Finntip 200 Ext (Sterile)
MBP 200MicroPoint Design
Medicine Products: